Epoch 27 - Decoding Long COVID

Near Term Therapeutic Solution Unlikely

Hello Avatar! Welcome back for another week of biotech analysis.  For most of us in “the bio-business” travel is a major component of the job description.  As we begin to hit the road again we are noting many colleagues contracting COVID.   With new variants emerging almost every few weeks, COVID has proven to be a challenging virus to keep up with from…